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INTRODUCTION
Renal allograft biopsies have been used as
a good method for monitoring the evolution of
kidney transplants for at least 20 years.
1
Histological analysis permits differential diagnosis
of the causes of allograft dysfunction to be made.
Such an evaluation can lead to the avoidance of
the use of additional immunosuppressive drugs,
thereby reducing the incidence of complications.
1,2
The usual position of an allograft in the iliac fossa
renders it easily palpable and accessible to safe
needle biopsy.
1
 However, the risk of accidents
leading to loss of the allografts is still around 1%.
3
Sufficient material for histological evaluation is
generally obtained in about 90% of the cases.
3
In the present study, we analyzed 339
percutaneous needle allograft biopsies from 135
patients and compared these results with the
clinical presentation and laboratory data
obtained before the biopsy as well as with the
incidence of complications.
METHODS
From November 1986 to December 1991,
339 percutaneous biopsies were obtained from
135 renal transplant patients.
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ABSTRACT
Context: Renal allograft biopsies have been used as a
good method for monitoring the evolution of kidney
transplants for at least 20 years.
1
 Histological analysis
permits differential diagnosis of the causes of allograft
dysfunction to be made.
Objectives: To correlate the data of urinalysis and serum
creatinine with histological diagnosis of renal graft in a
group of renal transplant patients.
Design: Accuracy study, retrospective analysis.
Setting: A university terciary referral center.
Sample: 339 percutaneous allograft biopsies obtained
from 153 patients. Blood and urine samples were obtained
before the graft biopsy.
Main Measurements: Laboratory evaluation and
hystological analysis (light microscopy, imunofluorescent
eletronic microscopy).
Results:  Most of the biopsies (58.9%) were performed
during the first month post-transplant. An increase in serum
creatinine was associated with acute tubular and/or
cortical necrosis. Proteinuria and normal serum creatinine
were associated with glomerular lesions. Non-nephrotic
range proteinuria and an increase in serum creatinine were
associated with chronic rejection.
Conclusion: Evaluation of serum creatinine and urinalysis
can be useful in suggesting the histological graft diagnosis.
Key words: Kidney transplantation. Renal biopsy. Acute
rejection. Acute tubular necrosis. Glomerulonephritis.
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The usual immunosuppressive protocol
included azathioprine (2 mg/kg/day) and
prednisone (2 mg/kg/day) for recipients of a
transplant from a living related HLA-identical
sibling donor, and cyclosporine (7 mg/kg/day)
for recipients of a transplant from a living related
non-identical or cadaver donor. Prednisone was
progressively reduced to 10 mg/day at the third
month post-transplant, and the cyclosporine dose
was adjusted to maintain blood levels around
100 to 200 ng/dl as determined by a
monoclonal antibody radioimmunoassay.
Acute rejection episodes were treated with
a pulse of methylprednisolone (500 mg/day, IV),
for three days.
Laboratory evaluation. Blood and urine
samples were collected before renal biopsy. The
urinary analysis involved sediment and
biochemical tests. When proteinuria was positive,
24 hour urine samples were collected for the
quantification of protein. The blood samples were
analyzed for their creatinine (Jaffé method) and
cyclosporine levels as well as their ability to
coagulate.
Indications for percutaneous needle
allograft biopsy. Percutaneous needle allograft
biopsy was indicated when at least one of the
following criteria was present:
1. An increase in the serum creatinine level to
more than 25% above basal.
2. Signs and symptoms of acute rejection,
including fever, edema, arterial hypertension,
renal pain, body weight gain, eosinphilia,
oliguria and elevation of serum creatinine
levels.
3. Cadaver kidney recipients with oliguria or
anuria and/or stable serum creatinine levels
above normal values (> 2 mg%).
4. Unsuccessful treatment of the acute rejection
with methylprednisolone.
5. Abnormal urinalysis with glomerular
hematuria, proteinuria in isolated samples
and/or hematic or leukocytic casts.
6. Twenty-four hour proteinuria above 1 g/day.
Biopsy Procedure. Prior to renal biopsy, the
patients had their blood pressure controlled and
their blood coagulation parameters determined.
In addition, the allografts were evaluated by renal
ultrasound. If other causes of renal dysfunction
such as vascular or ureteral obstruction were
conclusively discarded, the renal biopsy was
performed. Vin-Silverman-Franklin or discardable
Tru-Cut Travenol

 needles were used. Usually the
needle was positioned in the convex lateral
border in the superior pole and, after local
anesthesia, was introduced in a perpendicular
position, followed by the removal of one or two
tissue fragments. Post-biopsy hematuria was
monitored by the visual inspection of urine
samples on three separate occasions.
Histological Analysis. Renal biopsy
fragments were considered adequate if they
contained cortical or cortical/medullar junction
tissue. Samples containing only medullar tissue
were inadequate for diagnosis, and another
biopsy was performed. The biopsy material was
processed in the University Department of
Pathological Anatomy. Fragments were
examined by light microscopy following HE, PAS
and Masson staining. Immunofluorescent staining
was done with antiserum to IgM, IgG, IgA, C3,
C1q, kappa and lambda. Some samples were
examined by electron microscopy.
Statistical Methods. Statistical analysis was
carried out using the chi-square test and unpaired
Student’s t test.
RESULTS
From November 1986 to December 1991,
339 needle allograft biopsies were obtained from
135 renal transplant patients (95M, 40F), out of
a total of 247 such transplants performed during
Table 1 - Number of percutaneous graft biopsies
performed per patient during study period
donor patients number of relationship
graft biopsies  biopsy/patient
identical HLA 14 26 1.85
non-identical HLA 57 119 2.08
cadaver 64 194    3.03 *
Total 135 339 2.51
* p < 0.05 (chi-square test)
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this period. The number of biopsies per patient
(Table 1) was significantly greater in individuals
receiving a kidney from cadaver donors (p <
0.05). In 64 such recipients, 194 biopsies were
done, compared to 145 biopsies in 71 patients
receiving a kidney from related living donors (14
HLA-identical and 57 non-identical).
The indications for renal biopsy were graft
dysfunction in 272 instances (80.2%), anuria in
34 (10.0%) and abnormal urinalysis in 33
(9.8%). Graft dysfunction (n = 272) was
associated with oliguria in 74 instances (27.2%)
and no response to rejection treatment in 15
(5.5%). In the patients for whom allograft biopsy
was indicated by abnormal urinalysis, the most
frequent abnormality observed was isolated
proteinuria (in 20 biopsies) followed by
proteinuria in association with glomerular
hematuria in six biopsies. Isolated glomerular
hematuria was the cause of renal biopsy on seven
occasions (Table 2). One hundred and eighty-
three biopsies (53.9%) were done during the first
month post-transplant, with a gradual reduction
in the number thereafter. In the first year after the
renal transplant, 302 biopsies (89%) were
performed (Table 3). Adequate material for
analysis was obtained in 306 fragments (91.1%).
Severe hemorragic complications occurred in four
cases, and led to graft loss in two.
Acute rejection was observed in 136
fragments (40.1%), 106 of them during the first
two months post-transplant and four after the first
year. In this group, renal dysfunction was the
main indicator of renal biopsy in 127 instances,
followed by anuria in seven and abnormal
urinalysis in two. Acute cellular rejection (ACR)
without a vascular component or acute tubular
necrosis was observed in 57 biopsies. ACR
associated with acute tubular necrosis was seen
in 47 instances and was associated with vascular
rejection in 32 fragments. No difference in the
incidence of ACR was observed between
recipients of cadaver or living-related donor
organs.
Acute tubular necrosis (ATN) was the
second most frequent diagnosis (66 biopsies,
19.4%). As with ACR, acute tubular necrosis was
observed mainly during the first two months post-
transplant (62 cases). The histological diagnosis
of ATN was more frequent in cadaver donor
recipients. In individuals with ATN, the indication
for biopsy was renal dysfunction in 52 instances,
anuria in 12 and abnormal urinalysis in two.
Chronic rejection was observed in 40
fragments (11.7%). This diagnosis became more
frequent after the sixth month post-transplant
(Table 3). Renal dysfunction was again the major
indicator of the need for a biopsy. In 26
fragments, a glomerular lesion was detected.
Glomerulonephritis (GN) was diagnosed
in 27 biopsies (7.9%). Focal and segmental
glomerulosclerosis was the most frequent
diagnosis, occurring in ten biopsies from eight
patients. Mesangiocapillary type I GN was
observed in seven biopsies from four patients,
and type III in two biopsies from two patients.
Membranous GN occurred in two fragments from
two patients. In one patient, the diagnosis was
mesangial proliferative GN. In this group,
proteinuria (7.71g, SD 8.82) was greater than
in others, while serum creatinine (2.36mg/dl,
SD 1.99) was the lowest among the various
groups. In living donor recipients, the diagnosis
of GN was more frequent than in cadaver ones.
Acute vascular rejection was observed in
14 fragments (4.1%) from 11 patients. Graft loss
occurred in all patients within two months after
diagnosis. All biopsy indications were based on
renal dysfunction. The urinalysis (proteinuria
below 1 g/l, hematuria < 50 RBC per high power
field) and serum creatinine levels (6.45 mg/dl)
were similar to ACR group.
Table 2 - Indications for percutaneous graft biopsies
Indications number (%)
Graft dysfunction 272 (80.2%)
   - with oliguria   74
   - no response to anti-rejection treatment   15
Anuria 34 (10.0%)
Abnormal urinalysis 33 (9.8%)
   - isolated proteinuria   20
   - proteinuria + glomerular hematuria   6
   - isolated glomerular hematuria   7
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Cortical necrosis was the diagnosis in 13
fragments (3.8%), and in 12 of them the
indication for renal biopsy was anuria. All
biopsies were done in the first month post-
transplant. A total of seven patients were included
in this group and all the grafts were removed.
DISCUSSION
Percutaneous needle allograft biopsy may
be performed in order to evaluate the renal
function of kidney transplant patients. The position
of the allograft in the iliac fossa permits easy
access for the biopsy procedure. The kidney can
be localized by bimanual palpation and
hemostasis is facilitated by the use of a
compressive technique.
3
 Adequate material for
histological analysis, containing cortical and
cortical/medullar junction material is obtained
in 80% to 100% of renal biopsies. Renal biopsy
accidents that result in kidney loss are rare,
occurring in about 1% of the cases. In the present
study, the incidence of allograft loss after
percutaneous needle biopsy was 1.5% (2 graft
losses for 135 patients).
The major indication for kidney transplant
biopsy was the differential diagnosis of acute
rejection and renal dysfunction. This indication was
based on the increase in serum creatinine levels.
Probable differential diagnoses included acute
vascular rejection, chronic rejection, acute tubular
necrosis and cyclosporine nephrotoxicity. Matas
1
suggested that 40% of renal transplant patients
presented no changes in their immunosuppressive
therapy after renal allograft biopsy. In the present
study, unchanged immunosuppression was
observed in 38% of the cases.
The usefulness of urinalysis as an indicator
for allograft biopsy is controversial. Hematuria
has no value either as an indicator for renal
biopsy or in the prognosis of renal function.
Proteinuria is an important marker and has been
extensively studied.
4,5,6,7
 Massive proteinuria after
transplant is frequent during the first three months,
with spontaneous remission during evolution.
4
Persistent proteinuria occurs in about 30% of
transplants, and is positively correlated with the
presence of glomerular lesions, which is
indicative of chronic rejection or
glomerulonephritis. Persistent proteinuria is one
of the most frequent indicators for renal biopsy.
In the present study, proteinuria was used as an
indicator for allograft biopsy in 7.6% of the cases,
and was present in 21.6% of the renal biopsies.
Abnormal urinalysis was indicative of
allograft biopsy in 10% of the cases, especially
after the third month post-transplant. The
histological diagnoses were chronic rejection and
glomerular disease.
Acute tubular necrosis (ATN) occurs in
about 30 to 60% of cadaver kidney recipients
and in about 10% of recipients from living
donors.
8
 The former incidence may be associated
with extended periods of cold organ storage that
can promote tissue ischemia and acute tubular
necrosis. The hemodynamic status of the donor
can also influence the onset of acute tubular
necrosis.
8,9
 In our study, ATN occurred in 29.3%
Table 3 - Time post-transplant when graft biopsies were performed
Days ACR AVR ATN CR GN other total
1|| 30 92 7 51 0 0 33 183
31|| 60 14 7 11 0 3 4 39
61|| 180 22 0 3 6 8 6 45
181|| 365 4 0 1 14 7 9 35
after 1st year 4 0 0 20 9 4 37
Total 136 14 66 40 27 56 339
ACR = acute cellular rejection, AVR = acute vascular rejection, ATN = acute tubular necrosis, CR = chronic rejection, GN =
glomerulonephritis. *other: medullar (n=33), cortical necrosis (n=13), hemolytic uremic syndrome (n=3), Cyclosporine nephrotoxic-
ity (n=2), chronic pyelonephritis (n=2), normal (n=1), granulomatosis (n=1), nephrosclerosis (n=1).
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of the patients (74.3% received a kidney from a
cadaver donor and 25.6% from a living donor).
Urinalysis was not important in this group, since
the presence of non-glomerular hematuria and
leukocyturia could have been secondary to the
post-operatory period or to the presence of a
bladder catheter.
Acute rejection is considered to be the most
frequent cause of allograft dysfunction and
usually occurs during the first three months post-
transplant.
1,2
 In the present study, we observed
acute rejection in 40.1% of the biopsies. The
incidence of acute rejection was similar between
recipients from cadaver or living related donors.
Acute rejection associated with ATN was a
frequent histological observation in our patients.
This association may reflect antigen presentation
by necrotic tubule cells which results in a rejection
process.
8
Acute vascular rejection can be secondary
to the presence of humoral factors.
10
 Vascular
rejection is considered a poor prognostic
indicator, because the intimal infiltrate can lead
to occlusive arteriolopathy and tissue ischemia.
11
Individuals in this group had short survival since
the aggressive immunosuppressive therapy can
promote infectious complications and death of
the patient. In our series, acute vascular rejection
was associated with long-term graft loss in 100%
of the cases. The histological analysis showed
renal cor tical ischemia and obliterative
arteriolopathy, secondary to intimal growth,
suggestive of endothelial disease.
Chronic rejection occurs frequently after the
sixth month post-transplant and progresses to
chronic renal failure.
12
 The condition occurs in
about 17% of renal transplants, although in our
series the incidence of chronic rejection was
11.8% (40 histological diagnoses in 21 patients).
The clinical diagnosis was based on an increase
in serum creatinine levels, usually in the presence
of normal urinalysis. The average level of isolated
proteinuria was about 1.31 g. Histological
evaluation showed tubular atrophy, interstitial
fibrosis and thickening of vascular walls, all of
which suggest ischemic disease. Varying degrees
of glomerular sclerosis were also present. The
differential diagnosis between transplant
glomerulopathy, chronic rejection and segmental
glomerulosclerosis can be difficult.
Immunofluorescence and electron microscopy
can be helpful in such cases.
Post-transplant glomerulonephritis is
frequent, but classification as de novo, recurrent
or indeterminate is difficult since the primary renal
disease is rarely diagnosed. Such
glomerulonephritis can be due to persistent
systemic factors,
13
 donor glomerular disease,
14




introduction, cyclosporine has been found to be
a further factor causing glomerular lesions
15,16
Histologically, glomerular lesions can be
superposed since, as with ischemia, hypertension
and immunological or toxic factors, the
pathogenic mechanisms can lead to endothelial
injury
17
 which in turn produces focal and
segmental glomerulosclerosis, usually in the
vascular pole of the glomerulus. These
mechanisms can promote thickening of the basal
membrane. In short, the histological analysis of
biopsy fragments by optical microscopy alone,
along with imprecise diagnosis of the primary
renal disease, does not permit correct diagnosis
of post-transplant glomerular disease.
The differential diagnosis of chronic
rejection, cyclosporine-mediated nephrotoxicity
and focal and segmental glomerulosclerosis
requires immunofluorescence and electron
microscopy. The serum levels of cyclosporine may
also be useful in such diagnoses.
17,18
In summary, percutaneous needle allograft
biopsy is an useful procedure in the follow-up of
kidney transplants. Since such biopsies permit a
differentiation between rejection and any other
causes of allograft dysfunction, they should prove
to be useful in determining adequate
immunosuppressive therapy and in reducing the
risk of complications.
The only laboratory data that generally
correlated with the histological diagnosis was
the elevation in serum creatinine levels associated
with ATN or cortical necrosis. Proteinuria with
normal creatinine levels was associated with
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glomerular lesions, usually after the sixth month
post-transplant. Late proteinuria in the non-
nephrotic range associated with increased
creatinine levels may be indicative of chronic
rejection.
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RESUMO
Contexto: Biópsia percutânea do rim transplantado tem representado um bom método para monitorização da evolução
funcional do enxerto há pelo menos 20 anos. A análise histológica nos permite o diagnóstico deferencial entre as várias
causas de disfunção do enxerto. Objetivos: Correlacionar, em pacientes transplantados renais, o exame simples de urina e a
creatinina sérica com achados histológicos do enxerto renal. Tipo de Estudo: Estudo da acurácia, análise retrospectiva.
Local: Hospital das Clínicas da UNICAMP. Amostra: 339 biopsias renais percutâneas (de 135 pacientes transplantados) no
período de janeiro de 1984 a dezembro de 1991. Amostras de sangue e de urina foram coletadas antes da biopsia renal.
Variáveis estudadas: Avaliação laboratorial e análise histológica. Resultados: Em 94,1% das indicações de biopsia foi
obtido material para análise histológica. Em 58,9% das biopsias a indicação ocorreu no primeiro mês de transplante.
Elevação da creatinina sérica associou-se a necrose tubular aguda e/ou necrose cortical. Proteinúria com níveis de creatinina
sérica dentro da normalidade associou-se a doenças glomerulares. Proteinúria (níveis não nefróticos) e aumento da creatinina
estiveram associados a rejeição crônica do transplante. Conclusão: A análise da creatinina sérica e do exame de urina em
pacientes transplantados renais pode sugerir o padrão histológico diferenciado de acometimento.
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